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Infection following total hip arthroplasties can be classified based on the timing of infection: early is defined as occurring within 1 month of prosthesis implantation, delayed occurring between 1 month and 1 year, and late infection occurring more than 1 year after implantation. With improvements in surgical technique and implant designs, survival rates of prosthesis have increased significantly\[[@ref1]\]. Unfortunately, prosthetic infection continues to be a serious complication, with incidences in large series reported up to 1.7% for primary THAs\[[@ref2]\]. Late infections by *Actinomyces israelii* has only been described in 3 cases in the English literature\[[@ref3]--[@ref5]\]. We report a further case of *A. israelii* causing infection in a prosthetic hip joint 9 years following implantation.

Case Report {#sec1-2}
===========

A 71-year-old man presented to outpatient clinic with right hip pain of 3 months duration. His past medical history included right and left total hip arthroplasties \[THA\] performed 9 and 10 years previously at another institution and Type 2 diabetes mellitus. Physical examination revealed clinical signs of localised pain in the right hip, with a reduced range of movement compared to the left. No further relevant symptoms were elicited. X-rays of the hip showed osteolysis of the femoral stem tip and were suspicious for loosening of the acetabular component.

The patient was admitted for investigation of an infected THA. Laboratory studies demonstrated elevated inflammatory markers with erythrocyte sedimentation rate of 71 mm/h and c-reactive protein of 65 mg/l. White cell count and blood glucose level were in the normal range.

Joint aspiration revealed purulent synovial fluid. Microscopic analysis identified many leukocytes but no microorganisms. A MRI scan was performed which revealed the presence of a collection around the prosthetic joint. Presuming an infected right THA, the patient underwent revision surgery, where the prosthesis was found to be loose and purulent fluid surrounded the joint. The prosthesis was removed and an antibiotic-loaded bone cement spacer was implanted. Several biopsies of periprosthetic tissue were taken intra-operatively for microbiological investigation and subjected to culture. In all specimens *Actinomyces israelii* was isolated, sensitive to penicillin, teicoplanin, vancomycin, ciprofloxacin and linezolid.

Post-operatively the patient received intravenous teicoplanin, which was changed to vancomycin once antibiotic sensitivities were available. He received 6 weeks of intravenous antibiotics in total, before being discharged with ciprofloxacin and linezolid orally. He underwent the second-stage of the re-implantation arthroplasty 3 months following the first stage revision once inflammatory markers had normalised. Cultures and gram stains from the second-stage surgery was negative. The patient is now one-year post revision surgery. He is well with no clinical or laboratory evidence of infection.
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Infection after total joint arthroplasty is a serious complication. Early and delayed infections are mainly regarded as the result of bacterial seeding in the perioperative period, whereas late infections are predominantly caused by haematogenous seeding from endogenous sites\[[@ref6]\]. Diabetes mellitus has been shown to increase the risk of infection in patients having primary arthroplasties\[[@ref2][@ref7]\]. Other risk factors include post-traumatic osteoarthritis, previous surgery, chronic liver disease, corticoid therapy and intravenous drug abuse\[[@ref8]\].

*Actinomyces israelii* is a filamentous gram-positive anaerobic bacterium of low pathogenicity that is frequently isolated from the gastrointestinal tract, bronchi, oral cavities and female genital tract\[[@ref4][@ref5]\]. Pathogenesis most commonly involves dental caries or gingival disease, with infections of the lung or abdomen being the next most common. *A. israelii* infection in THA is extremely rare, with 3 reported cases in literature. In the first case, infection developed 1 year after joint replacement where the authors could not rule out bacterial implantation at the time of surgery\[[@ref3]\]. In the second, infection developed 10 years after prosthesis implantation following dental work without antibiotic prophylaxis\[[@ref4]\]. In the third, infection was associated with intravenous drug abuse\[[@ref5]\]. In the present case, infection occurred 9 years after primary arthroplasty with diabetes mellitus the predominant risk factor.

Treatment of *A. israelii* infection in THA involves a combination of surgical and medicinal therapy. In all of the cases including the present study, the implant was removed surgically before the patient was commenced on high dose antibiotic therapy. In two cases, reimplantation surgery was possible once the microorganism was eradicated from the affected hip. One case was lost to follow-up and one case developed a fistulae which was later superinfected with Staphyloccocus aureus.
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==========

This is the first reported case of late haematogenous infection by *Actinomyces israelii* in a total hip arthroplasty in a patient with diabetes mellitus as the only risk factor. The patient was successfully treated with antibiotic therapy and two-stage reimplantation arthroplasty.
